GB1452344A - Stable viral preparations - Google Patents
Stable viral preparationsInfo
- Publication number
- GB1452344A GB1452344A GB559574A GB559574A GB1452344A GB 1452344 A GB1452344 A GB 1452344A GB 559574 A GB559574 A GB 559574A GB 559574 A GB559574 A GB 559574A GB 1452344 A GB1452344 A GB 1452344A
- Authority
- GB
- United Kingdom
- Prior art keywords
- virus
- suspension
- feb
- cell
- chelating agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 230000003612 virological effect Effects 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 5
- 239000000725 suspension Substances 0.000 abstract 4
- 229910052783 alkali metal Inorganic materials 0.000 abstract 2
- -1 alkaline earth metal salt Chemical class 0.000 abstract 2
- 239000002738 chelating agent Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 abstract 1
- 241001502481 Meleagrid alphaherpesvirus 1 Species 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 229940009662 edetate Drugs 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 230000003019 stabilising effect Effects 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16351—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16751—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US330912A US3915794A (en) | 1973-02-09 | 1973-02-09 | Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1452344A true GB1452344A (en) | 1976-10-13 |
Family
ID=23291840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB559574A Expired GB1452344A (en) | 1973-02-09 | 1974-02-07 | Stable viral preparations |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US3915794A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS5732043B2 (cg-RX-API-DMAC10.html) |
| AT (1) | AT331398B (cg-RX-API-DMAC10.html) |
| BE (1) | BE810555A (cg-RX-API-DMAC10.html) |
| CA (1) | CA1035700A (cg-RX-API-DMAC10.html) |
| CH (1) | CH592143A5 (cg-RX-API-DMAC10.html) |
| DD (1) | DD110306A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE2406167C2 (cg-RX-API-DMAC10.html) |
| DK (1) | DK134032B (cg-RX-API-DMAC10.html) |
| ES (1) | ES422961A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2216997B1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1452344A (cg-RX-API-DMAC10.html) |
| HU (1) | HU169120B (cg-RX-API-DMAC10.html) |
| IE (1) | IE38825B1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL44011A (cg-RX-API-DMAC10.html) |
| NL (1) | NL178013C (cg-RX-API-DMAC10.html) |
| SE (1) | SE427799B (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA74163B (cg-RX-API-DMAC10.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2144378C1 (ru) * | 1999-06-28 | 2000-01-20 | Всероссийский научно-исследовательский институт защиты животных | Вирусвакцина против болезни марека и способ ее изготовления |
| RU2144376C1 (ru) * | 1999-06-28 | 2000-01-20 | Всероссийский научно-исследовательский институт защиты животных | Сухая вирусвакцина против болезни марека и способ ее изготовления |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT71926B (en) * | 1979-10-29 | 1982-03-31 | Merck & Co Inc | Process for preparing a liquid vaccine comprising a stabilizer |
| JPS57114527A (en) * | 1979-10-29 | 1982-07-16 | Merck & Co Inc | Vaccine stabilizer |
| US4273762A (en) * | 1979-12-03 | 1981-06-16 | Merck & Co., Inc. | Lyophilization process for live viral compositions |
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| JPS6314729A (ja) * | 1986-06-30 | 1988-01-21 | スミスクライン・バイオロジカルス・ソシエテ・アノニム | 生ワクチン用改良安定剤、その製造法およびそれを含有するワクチン |
| US4847078A (en) * | 1987-01-14 | 1989-07-11 | Arseco, Inc. | Storage stable topical composition having moisture control agent |
| JPH01112853U (cg-RX-API-DMAC10.html) * | 1988-01-27 | 1989-07-28 | ||
| IL90188A0 (en) * | 1988-05-18 | 1989-12-15 | Cryopharm Corp | Process and medium for the lyophilization of erythrocytes |
| US5045446A (en) * | 1988-08-26 | 1991-09-03 | Cryopharm Corporation | Lyophilization of cells |
| WO1991018504A1 (en) * | 1990-05-25 | 1991-12-12 | Cryopharm Corporation | Process for lyophilizing cells, cell-like materials and platelets in a mixture of biocompatible amphipathic polymers |
| AU2088992A (en) * | 1992-05-05 | 1993-11-11 | Research Foundation For Microbial Diseases Of Osaka University, The | Stabilized live vaccine |
| CZ289574B6 (cs) * | 1992-06-04 | 2002-02-13 | Merck And Co., Inc. | Způsob výroby ľivé, atenuované vakcíny viru varicella zoster |
| US5360736A (en) * | 1992-06-04 | 1994-11-01 | Merck & Co., Inc. | Process for attenuated varicella zoster virus vaccine production |
| CA2158935A1 (en) * | 1993-10-12 | 1995-04-20 | Chiron Viagene, Inc. | Methods for preserving recombinant viruses |
| JP4386965B2 (ja) * | 1996-04-26 | 2009-12-16 | メルク エンド カンパニー インコーポレーテッド | Ｄｎａワクチン製剤 |
| ZA973642B (en) * | 1996-04-26 | 1997-11-25 | Merck & Co Inc | DNA vaccine formulations. |
| US6051238A (en) * | 1996-12-20 | 2000-04-18 | Merck & Co., Inc. | Stabilizers for lyophilized mumps vaccines |
| US6210683B1 (en) | 1997-09-05 | 2001-04-03 | Merck & Co., Inc. | Stabilizers containing recombinant human serum albumin for live virus vaccines |
| DE19812940A1 (de) * | 1998-03-24 | 1999-10-07 | Medigene Ag | Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung |
| US6926897B1 (en) * | 1998-03-24 | 2005-08-09 | Medigene Aktiengesellschaft | Medicament for the avoidance or treatment of papillomavirus-specific tumour |
| GB9808922D0 (en) * | 1998-04-24 | 1998-06-24 | Cantab Pharmaceuticals Res Ltd | Virus preparations |
| US6225289B1 (en) | 1998-12-10 | 2001-05-01 | Genvec, Inc. | Methods and compositions for preserving adenoviral vectors |
| FR2814957B1 (fr) * | 2000-10-06 | 2002-12-20 | Aventis Pasteur | Composition vaccinale et procede de stabilisation |
| US7013940B2 (en) * | 2001-04-19 | 2006-03-21 | Michelin Recherche Et Technique S.A. | Device for attenuating cavity noise in a tire and wheel |
| US7094412B2 (en) * | 2001-12-10 | 2006-08-22 | Bavarian Nordic A/S | Poxvirus containing formulations and process for preparing stable poxvirus containing compositions |
| TWI398272B (zh) * | 2005-03-08 | 2013-06-11 | Intervet Int Bv | 化學定義的安定劑 |
| EP1870649A1 (en) | 2006-06-20 | 2007-12-26 | Octapharma AG | Lyophilisation targetting defined residual moisture by limited desorption energy levels |
| CA2844927C (en) | 2011-08-12 | 2017-10-31 | Merial Limited | Vacuum-assisted preservation of biological products, in particular of vaccines |
| TWI690322B (zh) | 2012-10-02 | 2020-04-11 | 法商傳斯堅公司 | 含病毒的調配物及其使用 |
| WO2015175672A1 (en) | 2014-05-14 | 2015-11-19 | Merial, Inc. | Methods for freeze-drying and rehydrating biologics |
| US10517943B2 (en) * | 2014-12-01 | 2019-12-31 | Transgene S.A. | Stable liquid vaccinia virus formulations |
| CN105999287A (zh) * | 2016-07-01 | 2016-10-12 | 广东圣戈生物科技有限公司 | 一种疫苗稀释液及其制备方法 |
| UA125029C2 (uk) | 2016-10-05 | 2021-12-29 | Зоетіс Сервісіс Ллк | Спосіб ліофілізації, який забезпечує стабільно дегідратовані найпростіші для застосування як ефективних живих вакцин |
| WO2019048689A1 (en) | 2017-09-11 | 2019-03-14 | Imba - Institut Für Molekulare Biotechnologie Gmbh | TUMOR ORGANOID MODEL |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1292803A (en) * | 1968-11-18 | 1972-10-11 | Nat Res Dev | Improvements relating to the production of antigens |
| US3642574A (en) * | 1970-04-29 | 1972-02-15 | Us Agriculture | Method for producing vaccine for immunization of poultry against marek{3 s disease |
| US3783098A (en) * | 1971-08-10 | 1974-01-01 | Cornell Res Foundation Inc | Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same |
-
1973
- 1973-02-09 US US330912A patent/US3915794A/en not_active Expired - Lifetime
-
1974
- 1974-01-09 ZA ZA740163A patent/ZA74163B/xx unknown
- 1974-01-16 IL IL44011A patent/IL44011A/en unknown
- 1974-01-17 FR FR7401572A patent/FR2216997B1/fr not_active Expired
- 1974-02-04 CA CA191,632A patent/CA1035700A/en not_active Expired
- 1974-02-04 BE BE140507A patent/BE810555A/xx unknown
- 1974-02-04 CH CH151774A patent/CH592143A5/xx not_active IP Right Cessation
- 1974-02-04 IE IE203/74A patent/IE38825B1/xx unknown
- 1974-02-06 SE SE7401554A patent/SE427799B/xx not_active IP Right Cessation
- 1974-02-06 ES ES422961A patent/ES422961A1/es not_active Expired
- 1974-02-06 DK DK64774A patent/DK134032B/da not_active IP Right Cessation
- 1974-02-07 GB GB559574A patent/GB1452344A/en not_active Expired
- 1974-02-07 AT AT98274A patent/AT331398B/de not_active IP Right Cessation
- 1974-02-07 JP JP1581474A patent/JPS5732043B2/ja not_active Expired
- 1974-02-08 NL NLAANVRAGE7401786,A patent/NL178013C/xx not_active IP Right Cessation
- 1974-02-08 DD DD17647674A patent/DD110306A5/xx unknown
- 1974-02-08 DE DE2406167A patent/DE2406167C2/de not_active Expired
- 1974-02-08 HU HURE000547 patent/HU169120B/hu not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2144378C1 (ru) * | 1999-06-28 | 2000-01-20 | Всероссийский научно-исследовательский институт защиты животных | Вирусвакцина против болезни марека и способ ее изготовления |
| RU2144376C1 (ru) * | 1999-06-28 | 2000-01-20 | Всероссийский научно-исследовательский институт защиты животных | Сухая вирусвакцина против болезни марека и способ ее изготовления |
Also Published As
| Publication number | Publication date |
|---|---|
| CA1035700A (en) | 1978-08-01 |
| NL7401786A (cg-RX-API-DMAC10.html) | 1974-08-13 |
| DD110306A5 (cg-RX-API-DMAC10.html) | 1974-12-12 |
| JPS49109518A (cg-RX-API-DMAC10.html) | 1974-10-18 |
| ES422961A1 (es) | 1976-06-01 |
| NL178013B (nl) | 1985-08-01 |
| BE810555A (fr) | 1974-08-05 |
| ZA74163B (en) | 1974-11-27 |
| JPS5732043B2 (cg-RX-API-DMAC10.html) | 1982-07-08 |
| DE2406167C2 (de) | 1984-12-20 |
| HU169120B (cg-RX-API-DMAC10.html) | 1976-09-28 |
| AU6486574A (en) | 1975-07-24 |
| ATA98274A (de) | 1975-11-15 |
| DK134032B (da) | 1976-08-30 |
| IE38825B1 (en) | 1978-06-07 |
| US3915794A (en) | 1975-10-28 |
| DE2406167A1 (de) | 1974-08-15 |
| AT331398B (de) | 1976-08-25 |
| DK134032C (cg-RX-API-DMAC10.html) | 1977-02-07 |
| CH592143A5 (cg-RX-API-DMAC10.html) | 1977-10-14 |
| IE38825L (en) | 1974-08-09 |
| IL44011A0 (en) | 1974-05-16 |
| FR2216997A1 (cg-RX-API-DMAC10.html) | 1974-09-06 |
| NL178013C (nl) | 1986-01-02 |
| FR2216997B1 (cg-RX-API-DMAC10.html) | 1978-01-06 |
| SE427799B (sv) | 1983-05-09 |
| IL44011A (en) | 1977-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE38825L (en) | Stabile viral preparation | |
| IE802225L (en) | Vaccine stabilizer | |
| GB1463966A (en) | Depilatory formulation | |
| GB1423113A (en) | Aqueous cholesterol standard | |
| IE39281B1 (en) | Compisitions for radiographic scanning | |
| GB1488209A (en) | Nuclease resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid | |
| GB1469862A (en) | Therapeutic compositions containing etherified monosaccharide derivatives and method of using the same | |
| GB1489780A (en) | Process of preparing a stable composition containing a compound of the prostaglandin e group | |
| GB1515012A (en) | Bisulphite terminated oligomers | |
| GB1358790A (en) | Method for the production of maltose of high purifity | |
| IE40221L (en) | Influenza vaccines | |
| GB1471326A (en) | Corticosteroid phosphate salts/neomycin sulphate ophthalmic solution | |
| GB1243252A (en) | Stable poliomyelitis vaccines and process for their manufacture | |
| GB1512148A (en) | Iodophor solution | |
| ES427653A1 (es) | Procedimiento para la preparacion de nuevos acidos 3-hidro- xiacilaminometil-5-acilamino-2, 4, 6-triyodo-benzoicos. | |
| GB1502519A (en) | Process for the preparation of acyltaurides | |
| GB1427882A (en) | Oxytetracycline solutions | |
| GB1450524A (en) | 2,4,6-triiodo-5-methoxyacetamido-n-methylisophthalamic acid and salts acyl halides and esters thereof | |
| GB1481650A (en) | Chemical processes and products | |
| GB1532550A (en) | Agent for preventing cold turbidity in beer | |
| NO862226D0 (no) | Fremgangsmaate for fremstilling av en vanlig loesning av et hetero-polysakkarid, samt anvendelse av en slik loesning. | |
| GB1111563A (en) | Methods for preparing n-benzyl-n',n"-dimethylguanidine | |
| IE39184L (en) | 9-ß-D-ARABINOFURANOSYL PURINE | |
| ES8203016A1 (es) | Un procedimiento para la preparacion de una solucion acuosa inyectable de sales de metales alcalinas de acido canrenoicoy de furosemida. | |
| GB1386584A (en) | Method of preparation of purine sugar derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| 732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
| PCNP | Patent ceased through non-payment of renewal fee |